
OMEROS CORP — Investor Relations & Filings
Omeros Corporation is a biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics. The company leverages innovative science to build a diverse pipeline of first-in-class drug candidates designed to address challenging diseases and disorders with significant unmet medical needs. Omeros concentrates on developing therapeutics with novel mechanisms of action that target previously untapped receptors and enzymes, aiming to provide next-generation treatments for patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | |
| DEF 14A - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | |
| SCHEDULE 13G/A - OMEROS CORP (0001285819) (Subject) | 2026-03-27 | English | |
| 4 - OMEROS CORP (0001285819) (Issuer) | 2026-02-21 | English | |
| SCHEDULE 13G Filing | 2026-01-30 | English | |
| 4 Filing | 2026-01-14 | English |
Browse filings by year
23 years- 2026 7 filings
- 2025 36 filings
- 2024 29 filings
- 2023 39 filings
- 2022 51 filings
- 2021 37 filings
- 2020 45 filings
- 2019 47 filings
- 2018 36 filings
- 2017 44 filings
- 2016 67 filings
- 2015 45 filings
- 2014 45 filings
- 2013 50 filings
- 2012 42 filings
- 2011 34 filings
- 2010 49 filings
- 2009 39 filings
- 2008 12 filings
- 2007 2 filings
- 2006 2 filings
- 2005 1 filing
- 2004 4 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 39078996 | ARS - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | ||
| 39079103 | DEF 14A - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | ||
| 33062212 | SCHEDULE 13G/A - OMEROS CORP (0001285819) (Subject) | 2026-03-27 | English | ||
| 32700252 | 4 - OMEROS CORP (0001285819) (Issuer) | 2026-02-21 | English | ||
| 28665560 | SCHEDULE 13G Filing | 2026-01-30 | English | ||
| 28665570 | 4 Filing | 2026-01-14 | English | ||
| 28665565 | 8-K Filing | 2026-01-07 | English | ||
|
2025
8 filings
| |||||
| 11674670 | FORM 8-K | 2025-12-29 | English | ||
| 11674671 | FORM 8-K | 2025-12-01 | English | ||
| 11674672 | Regulatory Filings 2025 | 2025-11-14 | English | ||
| 11674673 | Regulatory Filings 2025 | 2025-11-14 | English | ||
| 11674674 | FORM 10-Q | 2025-11-13 | English | ||
| 11674675 | FORM 8-K | 2025-11-13 | English | ||
| 11674676 | Major Shareholding Notification 2025 | 2025-10-31 | English | ||
| 11674677 | FORM 4 | 2025-10-16 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Guhan Pharmaceutical Group Co., Ltd.
Develops traditional Chinese medicines and health products …
|
000590 | CN | Manufacturing |
|
Guilin Sanjin Pharmaceutical Co.,Ltd
Develops and manufactures proprietary Chinese medicines and…
|
002275 | CN | Manufacturing |
|
Guiyang Xintian Pharmaceutical Co.,Ltd.
Develops and manufactures proprietary Chinese medicines for…
|
002873 | CN | Manufacturing |
|
Guizhou Bailing Group Pharmaceutical Co., Ltd.
Produces Traditional Chinese and Miao medicines for respira…
|
002424 | CN | Manufacturing |
|
GUIZHOU SANLI PHARMACEUTICAL CO.,LTD.
Develops and manufactures TCM sprays for respiratory, throa…
|
603439 | CN | Manufacturing |
|
Guizhou Yibai Pharmaceutical Co.,Ltd
Develops modern Chinese and chemical medicines for oncology…
|
600594 | CN | Manufacturing |
|
Gujarat Inject (Kerala) Ltd.
Manufactures intravenous fluids and large volume parenteral…
|
524238 | IN | Manufacturing |
|
Gujarat Terce Laboratories Ltd
Develops and manufactures medicinal formulations across var…
|
524314 | IN | Manufacturing |
|
Gujarat Themis Biosyn Ltd.
Produces fermentation-based APIs and intermediates for ther…
|
GUJTHEM | IN | Manufacturing |
|
Gulf Pharmaceutical Industries
Leading generic pharma manufacturer and global insulin prod…
|
JULPHAR | AE | Manufacturing |
OMEROS CORP via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33369/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33369 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33369 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33369 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33369}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OMEROS CORP (id: 33369)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.